The reduction in price target by HC Wainwright & Co. suggests a revision of the expected future stock performance, which could lead to a negative short-term impact on Equillium's stock price. However, the maintenance of a Buy rating indicates the analyst's continued positive outlook on the company, which could mitigate some negative sentiment.